Additionally, while FT522 showed a 67% overall response rate in relapsed or refractory non-Hodgkin lymphoma ... generation program FT596 exhibited low activity in diffuse large B-cell lymphoma, ...

Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; multiple clinical data reports planned for 2025 -- -- Enrolling patients with LBCL (2L and after prior CD19 ...

Dave Coulier can likely expect a positive outcome amid his cancer journey, according to oncologist Dr. Brian Hill. Coulier, ...

Actor Dave Coulier, known for playing Uncle Joey on the TV series Full House, announced he has stage 3 non-Hodgkin's lymphoma ...

Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.

From producer Quincy Jones’ death from pancreatic cancer to an inspiring moment between The Rock and a fan at a store, here’s ...

BOSTON--Novotech, the global full-service clinical CRO shares new insights into the global clinical trial landscape for Diffuse Large B-Cell Lymphoma (DLBCL).

Manitoba Hydro is currently dealing with a large power outage in Winnipeg's northeast. North Transcona, Harbour View South, ...

The most common type is diffuse large B-cell lymphoma. Other aggressive types include mantle cell, lymphoblastic, Burkitt, ...

BioNTech is investing in a promising space in oncology by acquiring Biotheus’ PD-L1 and VEGF bispecific antibody.